Lawrence: /* Conclusion */

2025-06-03T21:06:51Z

Conclusion

← Older revision		Revision as of 21:06, 3 June 2025
Line 5:		Line 5:
	=== 1. Define the Research Question ===		=== 1. Define the Research Question ===
	* Primary focus: Is the intervention cost-effective compared to the control?		* Primary focus: Is the intervention cost-effective compared to the control?
	* Specify the perspective of the analysis:		* Specify the perspective of the [[analysis]]:
	** Healthcare system		** Healthcare system
	** Societal		** Societal
Line 48:		Line 48:

	=== 6. Randomization and Blinding ===		=== 6. Randomization and Blinding ===
	* Use proper randomization to eliminate bias in both outcomes and costs.		* Use proper [[randomization]] to eliminate bias in both outcomes and costs.
	* Blinding is ideal but may not apply to cost data.		* [[Blinding]] is ideal but may not apply to cost data.

	=== 7. Plan the Economic Evaluation ===		=== 7. Plan the Economic Evaluation ===
Line 91:		Line 91:
	== Conclusion ==		== Conclusion ==
	Cost-effectiveness trials help determine whether healthcare interventions provide good value. By integrating economic and clinical outcomes, these trials inform resource allocation and policy decisions in healthcare systems.		Cost-effectiveness trials help determine whether healthcare interventions provide good value. By integrating economic and clinical outcomes, these trials inform resource allocation and policy decisions in healthcare systems.
			----

			=== Bibliography ===

			# Drummond MF, Sculpher MJ, Claxton K, Stoddart GL, Torrance GW. Methods for the Economic Evaluation of Health Care Programmes. 4th ed. Oxford University Press; 2015.
			# Neumann PJ, Sanders GD, Russell LB, Siegel JE, Ganiats TG, editors. Cost-Effectiveness in Health and Medicine. 2nd ed. Oxford University Press; 2017.
			# Glick HA, Doshi JA, Sonnad SS, Polsky D. Economic Evaluation in Clinical Trials. 2nd ed. Oxford University Press; 2014.
			# Willan AR, Briggs AH. Statistical Analysis of Cost-Effectiveness Data. Chichester: Wiley; 2006.
			# Ramsey SD, Willke RJ, Glick H, et al. Cost-effectiveness analysis alongside clinical trials II: an ISPOR Good Research Practices Task Force report. ''Value in Health''. 2015;18(2):161–172.

			----
			''Adapted for educational use. Please cite relevant trial methodology sources when using this material in research or teaching.''

Lawrence: Created page with "== Cost-Effectiveness trials == A '''cost-effectiveness RCT''' integrates economic evaluation alongside clinical outcomes to assess whether an intervention provides good value for its cost. It combines health outcomes and resource use to inform healthcare decision-making. === 1. Define the Research Question === * Primary focus: Is the intervention cost-effective compared to the control? * Specify the perspective of the analysis: Healthcare system Societal ** Pay..."

2025-03-24T23:35:54Z

Created page with "== Cost-Effectiveness trials == A '''cost-effectiveness RCT''' integrates economic evaluation alongside clinical outcomes to assess whether an intervention provides good value for its cost. It combines health outcomes and resource use to inform healthcare decision-making. === 1. Define the Research Question === * Primary focus: Is the intervention cost-effective compared to the control? * Specify the perspective of the analysis: ** Healthcare system ** Societal ** Pay..."

New page

== Cost-Effectiveness trials ==

A '''cost-effectiveness RCT''' integrates economic evaluation alongside clinical outcomes to assess whether an intervention provides good value for its cost. It combines health outcomes and resource use to inform healthcare decision-making.

=== 1. Define the Research Question ===
* Primary focus: Is the intervention cost-effective compared to the control?
* Specify the perspective of the analysis:
** Healthcare system
** Societal
** Payer or patient
* '''Example''': Is Drug A more cost-effective than Drug B in reducing hospital readmissions?

=== 2. Choose the Appropriate Study Design ===
* '''Parallel-Group RCT''': Standard design where individuals are randomized to intervention or control.
* '''Cluster RCT''': Ideal for health system-level or practice-level interventions.

=== 3. Define the Outcome Measures ===

'''Clinical Outcomes'''
* Primary clinical outcomes (e.g., symptom reduction, mortality, quality of life).

'''Economic Outcomes'''
* '''Costs'''
** Direct: Medications, hospital visits, tests, diagnostics.
** Indirect: Lost productivity, travel costs, caregiver time.
* '''Effectiveness'''
** Use composite measures such as:
*** Quality-Adjusted Life Years (QALYs)
*** Disability-Adjusted Life Years (DALYs)
* '''Incremental Cost-Effectiveness Ratio (ICER)'''

''ICER'' = (Cost of Intervention – Cost of Control) ÷ (Effectiveness of Intervention – Effectiveness of Control)

=== 4. Sample Size Calculation ===
* Account for variability in both clinical and cost data.
* Ensure the trial is powered to detect differences in cost-effectiveness.
* Larger sample sizes are often needed due to high cost variability.

=== 5. Collect and Track Data ===

* '''Clinical Data:''' Standard RCT outcome collection.
* '''Cost Data:''' Use:
** Hospital billing data
** Insurance claims
** Self-reported cost/resource use questionnaires
* '''Quality of Life Data:'''
** Tools like EQ-5D, SF-36, or HUI for QALY estimation.

=== 6. Randomization and Blinding ===
* Use proper randomization to eliminate bias in both outcomes and costs.
* Blinding is ideal but may not apply to cost data.

=== 7. Plan the Economic Evaluation ===
* '''Perspective''': Define it clearly (e.g., societal vs. healthcare system).
* '''Time Horizon''':
** Short-term (trial duration)
** Long-term (lifetime, using modeling)
* '''Discounting''':
** Apply annual discount rates (e.g., 3–5%) for long-term projections.

=== 8. Statistical and Economic Analysis ===
* '''Clinical Analysis''': Intention-to-treat or per-protocol.
* '''Cost Analysis''':
** Calculate and compare mean costs.
** Use bootstrapping to estimate confidence intervals.
* '''Cost-Effectiveness Analysis (CEA)''':
** Present ICER values.
** Plot results on the cost-effectiveness plane.
* '''Cost-Effectiveness Acceptability Curve (CEAC)''':
** Shows probability that the intervention is cost-effective at varying willingness-to-pay thresholds.

=== 9. Address Uncertainty ===
* '''Sensitivity Analysis''':
** Deterministic: Change one input at a time.
** Probabilistic: Simulate variability across multiple parameters using distributions.
* Use Monte Carlo simulations for probabilistic models.

=== 10. Reporting and Dissemination ===
* Follow the '''CHEERS''' (Consolidated Health Economic Evaluation Reporting Standards) guidelines.
* Report both clinical and economic findings transparently.

=== Example Study Design ===

'''Research Question''': Is a digital health intervention for diabetes management cost-effective compared to standard care?

* '''Design''': Parallel-group RCT
* '''Clinical Outcomes''': HbA1c reduction, QALYs
* '''Cost Data''': Clinic visits, medication use, hospitalization, device costs
* '''Analysis''': Calculate ICER (cost per QALY gained)

== Conclusion ==
Cost-effectiveness trials help determine whether healthcare interventions provide good value. By integrating economic and clinical outcomes, these trials inform resource allocation and policy decisions in healthcare systems.

Cost effectiveness - Revision history

Lawrence: /* Conclusion */